News About Visit Website Latest News Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics Quoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders Aug. 9, 2023 8:30 AM ET Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders Jun. 13, 2023 8:30 AM ET Asensus Shares First Quarter Results and Future Plans Jun. 1, 2023 9:28 AM ET More News About Contact 6463513092 Visit Website A Pivotal Year Ahead for Quoin Pharmaceuticals Mar. 1, 2023 8:30 AM ET Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks Feb. 16, 2023 11:54 AM ET Lexaria Bioscience: Charting a Path to Commercial Success Jan. 31, 2023 8:30 AM ET Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 Jan. 12, 2023 8:30 AM ET Soligenix Delivers Two Pivotal Milestones Dec. 20, 2022 8:30 AM ET Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones Dec. 6, 2022 8:30 AM ET Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies Nov. 21, 2022 8:30 AM ET Soligenix Enters Q4 With Multiple Catalysts in Play Oct. 13, 2022 8:30 AM ET Lexaria Bioscience: Taking Aim at the $28 Billion Hypertension Market; Human Clinical Study Yields Remarkable Results Sep. 20, 2022 8:30 AM ET FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's HyBryte for CTCL Sep. 12, 2022 8:30 AM ET Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans Aug. 8, 2022 8:30 AM ET Soligenix's HyBryte Treatment Now Within Reach for Rare Cancer Patients Jul. 26, 2022 9:32 AM ET Virios Therapeutics (Nasdaq: VIRI) Advancing Potential Paradigm Shift in Fibromyalgia Treatment Jul. 26, 2022 8:55 AM ET Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results Jul. 19, 2022 8:30 AM ET The Ascension of Asensus in Performance-Guided Surgery Jun. 28, 2022 8:30 AM ET Quoin Pharmaceuticals: Strategically Building For Future Success Jun. 14, 2022 8:30 AM ET Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis Jun. 7, 2022 8:30 AM ET BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors May. 25, 2022 8:30 AM ET Quoin Pharmaceuticals: On track to Deliver the First FDA-approved Treatment for Netherton Syndrome May. 17, 2022 8:30 AM ET Snacks Sabotaging Your Sleep? Nightfood Establishes Nighttime Snacking Category May. 11, 2022 12:12 PM ET Investing in 60 Seconds: Asensus Surgical Apr. 20, 2022 8:30 AM ET Quoin Pharmaceuticals Targeting Regulatory Approvals for Lead Candidate for Netherton Syndrome in 2024 Mar. 24, 2022 8:30 AM ET Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy Feb. 8, 2022 8:30 AM ET Asensus Surgical: Reimagining the Future of Surgery Jan. 26, 2022 9:00 AM ET Soligenix Corporate Update Includes NDA Plans for HyBryte(TM) Jan. 12, 2022 12:00 PM ET The R&D Sweet Spot: Quoin Pharmaceuticals Delivering Value-Based Drug Development Through Rare and Orphan Disease Therapeutics Dec. 14, 2021 8:30 AM ET Soligenix Proof of Concept Uncovers Potential Treatment Option for the World's 125 Million Psoriasis Sufferers Nov. 30, 2021 8:30 AM ET Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline Nov. 16, 2021 8:30 AM ET Why Many Expect Nightfood to be King of the Night Snack Category Nov. 2, 2021 8:30 AM ET Lexaria THC Test Results Come in as MORE Act Gains Momentum in Congress Oct. 20, 2021 8:30 AM ET Highlights and Insights into Soligenix Oct. 13, 2021 8:30 AM ET Vaccine from Soligenix Could Accelerate Global Recovery from Covid-19 Pandemic Oct. 7, 2021 8:30 AM ET DehydraTECH Nicotine Pouches Could Make Smoking Obsolete Oct. 5, 2021 10:56 AM ET Nightfood Sleep-Friendly Snacks Enter Hospitality Industry, Helping Hotels Deliver Better Sleep for Guests Sep. 21, 2021 8:30 AM ET Lexaria Takes Another Step Towards NDA Filing for DehydraTECH- CBD Sep. 14, 2021 8:30 AM ET Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics Sep. 14, 2021 8:30 AM ET Winning Formulation; Lexaria Takes Strategic Aim at High Value Hypertension and Antiviral Therapeutics Markets with Robust Drug Delivery Technology Aug. 17, 2021 8:30 AM ET Who is preparing us for the next potential pandemic? Jul. 29, 2021 8:30 AM ET Solving the Night Snack Puzzle: Nightfood CEO Sean Folkson Talks Growth, Sleep, and a Billion-Dollar Opportunity Jul. 28, 2021 10:56 AM ET EcoChain to Benefit from Chinas Great Unplugging from Crypto Jul. 28, 2021 8:30 AM ET HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma Jul. 22, 2021 8:30 AM ET Nightfood: Go ahead; Snack before bedtime Jul. 13, 2021 8:30 AM ET QOEG Marketing Strategy Outpaces Competition in Developing Communities Jul. 13, 2021 8:30 AM ET Shining a Light on a New Hope for a Rare Form of Non-Hodgkins Lymphoma: Conversation with Dr. Ellen Kim on HyBryte(TM) from Soligenix Jul. 6, 2021 4:01 PM ET Offering New Hope for a Rare Form of non-Hodgkins Lymphoma: A Discussion with Dr. Ellen Kim on HyBryte(TM) from Soligenix Jul. 6, 2021 8:30 AM ET Nightfood: Helping America Rest Easier, One Scoop at a Time Jun. 24, 2021 10:38 AM ET Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM) Jun. 17, 2021 8:30 AM ET Nighttime Snacking Market Soars Past $50 Billion, with Nightfood Set to Take Center Stage Jun. 15, 2021 8:30 AM ET Shining a Light on Soligenixs HyBryte Growth Opportunity Jun. 3, 2021 8:30 AM ET Bubblr is Making All the Right Moves on the Road to Uplisting May. 27, 2021 8:30 AM ET Lexaria DehydraTECHTM 2.0 Outperforms MCT in 2021 R&D Study May. 25, 2021 8:30 AM ET AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash May. 20, 2021 3:28 PM ET LiveXLive Media Raises Guidance and Its Investor Presentations at Needham's & J.P. Morgans Tech & Media Conferences May. 20, 2021 8:30 AM ET AIKI Featured as Stock to Watch Ahead of Significant Key Milestones May. 19, 2021 8:30 AM ET AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives May. 13, 2021 8:30 AM ET When YouTubers Fight TikTokers, LiveXLive Wins May. 5, 2021 8:30 AM ET Award-Winning E-Learning Platform Projects Rapid Growth in New Markets with "Mommy Influencer" Sales System Apr. 29, 2021 8:30 AM ET Lexaria Bioscience: Turning the Tide on Hypertension Apr. 15, 2021 8:30 AM ET Lexaria is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace Apr. 8, 2021 8:30 AM ET UPDATE: LiveXLive Leverages Diverse Channel Strategy to Accelerate Marked Growth Apr. 5, 2021 9:55 AM ET LiveXLive Leverages Diverse Channel Strategy to Accelerate Marked Growth Mar. 31, 2021 8:30 AM ET Soligenix Anticipated to Achieve Multiple Milestones in 2021 Mar. 16, 2021 8:30 AM ET Why Hidden Value Stock Bubblr (OTC:BBLR) is on a Mission to Fix the Internet Mar. 16, 2021 8:30 AM ET Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria? Mar. 9, 2021 8:30 AM ET As Investors Pile into Responsible Funds, Ethical Tech Company Bubblr Positions for Positive Impact on the Online Economy Feb. 23, 2021 8:30 AM ET Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track Feb. 23, 2021 8:30 AM ET Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 Feb. 9, 2021 8:30 AM ET U.S. Patent Follows Key Advisory Board Additions -- What's Next for Bubblr (OTC:BBLR)? Feb. 9, 2021 8:30 AM ET Lexaria Outlook is Promising After Jazz Acquisition of GW Feb. 9, 2021 8:30 AM ET Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma Jan. 25, 2021 8:00 AM ET Soligenix, Inc. (NASDAQ: SNGX) COVID-19 Vaccine Candidate, CiVax, Could Be a More Viable Alternative to Moderna and Pfizer Dec. 9, 2020 8:30 AM ET Pfizer And Moderna Covid-19 Vaccine Candidates Are Promising, But Soligenix's CiVax May Be A Better Alternative Nov. 17, 2020 8:00 AM ET With FDA and EU Marketing Authorizations in Hand, 2020 and 2021 Can Be Catalyst Years for Arch Therapeutics Sep. 22, 2020 8:30 AM ET Soligenix's RiVax(R) Program Back in Focus After Deadly Ricin Toxin Intercepted Before Reaching White House Sep. 21, 2020 8:30 AM ET
Quoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders Aug. 9, 2023 8:30 AM ET
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders Jun. 13, 2023 8:30 AM ET
Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks Feb. 16, 2023 11:54 AM ET
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 Jan. 12, 2023 8:30 AM ET
Lexaria Bioscience: Taking Aim at the $28 Billion Hypertension Market; Human Clinical Study Yields Remarkable Results Sep. 20, 2022 8:30 AM ET
FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's HyBryte for CTCL Sep. 12, 2022 8:30 AM ET
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans Aug. 8, 2022 8:30 AM ET
Virios Therapeutics (Nasdaq: VIRI) Advancing Potential Paradigm Shift in Fibromyalgia Treatment Jul. 26, 2022 8:55 AM ET
Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results Jul. 19, 2022 8:30 AM ET
Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis Jun. 7, 2022 8:30 AM ET
BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors May. 25, 2022 8:30 AM ET
Quoin Pharmaceuticals: On track to Deliver the First FDA-approved Treatment for Netherton Syndrome May. 17, 2022 8:30 AM ET
Snacks Sabotaging Your Sleep? Nightfood Establishes Nighttime Snacking Category May. 11, 2022 12:12 PM ET
Quoin Pharmaceuticals Targeting Regulatory Approvals for Lead Candidate for Netherton Syndrome in 2024 Mar. 24, 2022 8:30 AM ET
Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy Feb. 8, 2022 8:30 AM ET
The R&D Sweet Spot: Quoin Pharmaceuticals Delivering Value-Based Drug Development Through Rare and Orphan Disease Therapeutics Dec. 14, 2021 8:30 AM ET
Soligenix Proof of Concept Uncovers Potential Treatment Option for the World's 125 Million Psoriasis Sufferers Nov. 30, 2021 8:30 AM ET
Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline Nov. 16, 2021 8:30 AM ET
Vaccine from Soligenix Could Accelerate Global Recovery from Covid-19 Pandemic Oct. 7, 2021 8:30 AM ET
Nightfood Sleep-Friendly Snacks Enter Hospitality Industry, Helping Hotels Deliver Better Sleep for Guests Sep. 21, 2021 8:30 AM ET
Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics Sep. 14, 2021 8:30 AM ET
Winning Formulation; Lexaria Takes Strategic Aim at High Value Hypertension and Antiviral Therapeutics Markets with Robust Drug Delivery Technology Aug. 17, 2021 8:30 AM ET
Solving the Night Snack Puzzle: Nightfood CEO Sean Folkson Talks Growth, Sleep, and a Billion-Dollar Opportunity Jul. 28, 2021 10:56 AM ET
Shining a Light on a New Hope for a Rare Form of Non-Hodgkins Lymphoma: Conversation with Dr. Ellen Kim on HyBryte(TM) from Soligenix Jul. 6, 2021 4:01 PM ET
Offering New Hope for a Rare Form of non-Hodgkins Lymphoma: A Discussion with Dr. Ellen Kim on HyBryte(TM) from Soligenix Jul. 6, 2021 8:30 AM ET
Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM) Jun. 17, 2021 8:30 AM ET
Nighttime Snacking Market Soars Past $50 Billion, with Nightfood Set to Take Center Stage Jun. 15, 2021 8:30 AM ET
AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash May. 20, 2021 3:28 PM ET
LiveXLive Media Raises Guidance and Its Investor Presentations at Needham's & J.P. Morgans Tech & Media Conferences May. 20, 2021 8:30 AM ET
AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives May. 13, 2021 8:30 AM ET
Award-Winning E-Learning Platform Projects Rapid Growth in New Markets with "Mommy Influencer" Sales System Apr. 29, 2021 8:30 AM ET
Lexaria is Expanding CBD Use Beyond Medical Applications into $2.65 Billion Marketplace Apr. 8, 2021 8:30 AM ET
UPDATE: LiveXLive Leverages Diverse Channel Strategy to Accelerate Marked Growth Apr. 5, 2021 9:55 AM ET
Why Hidden Value Stock Bubblr (OTC:BBLR) is on a Mission to Fix the Internet Mar. 16, 2021 8:30 AM ET
As Investors Pile into Responsible Funds, Ethical Tech Company Bubblr Positions for Positive Impact on the Online Economy Feb. 23, 2021 8:30 AM ET
Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track Feb. 23, 2021 8:30 AM ET
Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 Feb. 9, 2021 8:30 AM ET
U.S. Patent Follows Key Advisory Board Additions -- What's Next for Bubblr (OTC:BBLR)? Feb. 9, 2021 8:30 AM ET
Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma Jan. 25, 2021 8:00 AM ET
Soligenix, Inc. (NASDAQ: SNGX) COVID-19 Vaccine Candidate, CiVax, Could Be a More Viable Alternative to Moderna and Pfizer Dec. 9, 2020 8:30 AM ET
Pfizer And Moderna Covid-19 Vaccine Candidates Are Promising, But Soligenix's CiVax May Be A Better Alternative Nov. 17, 2020 8:00 AM ET
With FDA and EU Marketing Authorizations in Hand, 2020 and 2021 Can Be Catalyst Years for Arch Therapeutics Sep. 22, 2020 8:30 AM ET
Soligenix's RiVax(R) Program Back in Focus After Deadly Ricin Toxin Intercepted Before Reaching White House Sep. 21, 2020 8:30 AM ET
